Still more rain descends on the nation's medicine chest, making for a soggy end to the week. What better excuse, then, for a hot cup of something and a few minutes to catch up with these...
Biovail Readies For Difficult Meeting With The FDA (The Toronto Globe and Mail)
UK High Court Tells NICE To Re-examine Eisai's Alzheimer's Drug (PharmaTimes)
Novartis Wins Diovan Patent Extension After Pediatric Testing (Bloomberg News)
Schering-Plough Prices Public Offering At $27.50 (Yahoo/AP)
Bradley Pharmaceuticals Has Three Potential Buyers (Yahoo/AP)
MedImmune CEO Wants More R&D Hires (Washington Business Journal)